13 results on '"LADENHEIM, BRUCE"'
Search Results
2. Amphetamine causes dopamine depletion and cell death in the mouse olfactory bulb
- Author
-
Atianjoh, Fidelis E., Ladenheim, Bruce, Krasnova, Irina N., and Cadet, Jean Lud
- Published
- 2008
- Full Text
- View/download PDF
3. Methamphetamine Administration Causes Death of Dopaminergic Neurons in the Mouse Olfactory Bulb
- Author
-
Deng, Xiaolin, Ladenheim, Bruce, Jayanthi, Subramaniam, and Cadet, Jean Lud
- Subjects
- *
METHAMPHETAMINE , *DRUG abuse , *MENTAL illness , *DOPAMINE , *DOPAMINERGIC neurons - Abstract
Background: Methamphetamine (METH) is an addictive drug that can cause neurological and psychiatric disorders. In the rodent brain, toxic doses of METH cause damage of dopaminergic terminals and apoptosis of nondopaminergic neurons. The olfactory bulb (OB) is a brain region that is rich with dopaminergic neurons and terminals. Methods: Rats were given a single injection of METH (40 mg/kg) and sacrificed at various time points afterward. The toxic effects of this injection on the OB were assessed by measuring monoamine levels, tyrosine hydroxylase (TH) immunocytochemistry, terminal deoxynucleotidyl transferase-mediated deoxyribonucleotide triphosphate (dNTP) nick end labeling (TUNEL) histochemistry, and caspase-3 immunochemistry. Results: Methamphetamine administration caused marked decreases in dopamine (DA) levels and TH-like immunostaining in the mouse OB. The drug also caused increases in TUNEL-labeled OB neurons, some of which were also positive for TH expression. Moreover, there was METH-induced expression of activated caspase-3 in TH-positive cells. Finally, the METH injection was associated with increased expression of the proapoptotic proteins, Bax and Bid, but with decreased expression of the antideath protein, Bcl2. Conclusions: These observations show, for the first time, that METH can cause loss of OB DA terminals and death of DA neurons, in part, via mechanisms that are akin to an apoptotic process. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
4. 54. Genome-Wide Transcriptional Analysis Identifies Cellular Adhesion Molecules as Regulators of Compulsive Methamphetamine Intake in the Presence of Adverse Consequences.
- Author
-
Cadet, Jean Lud, Munoz, Ceiveon, Ladenheim, Bruce, and Jayanthi, Subramaniam
- Subjects
- *
CELL analysis , *METHAMPHETAMINE , *MOLECULES - Published
- 2023
- Full Text
- View/download PDF
5. Compulsive methamphetamine taking under punishment is associated with greater cue-induced drug seeking in rats.
- Author
-
Torres, Oscar V., Jayanthi, Subramanian, Ladenheim, Bruce, McCoy, Michael T., Krasnova, Irina N., and Cadet, Jean Lud
- Subjects
- *
METHAMPHETAMINE abuse , *COMPULSIVE behavior , *DRUG-seeking behavior , *PUNISHMENT , *LABORATORY rats - Abstract
Methamphetamine (METH) addicts lose control over drug consumption despite suffering multiple adverse medicolegal consequences. To mimic the negative events associated with drug addiction in humans, we recently introduced a rat model of self-administration (SA) with response-contingent punishment on METH intake. These procedures allowed us to distinguish between two addiction-like phenotypes in rats, those that sustained METH taking despite negative consequences (shock-resistant, SR) and rats that significantly reduced their METH intake (shock-sensitive, SS). Here, we further developed our adverse consequence model and examined incubation of METH craving by measuring cue-induced drug seeking in SR and SS rats. Male Sprague–Dawley rats were trained to self-administer METH (0.1 mg/kg/injection) or saline intravenously (i.v.) during twenty-two 9-h sessions that consisted of 3 separate 3-h sessions separated by 30 min. Subsequently, rats were subjected to incremental footshocks during thirteen additional 9-h METH SA sessions performed in a fashion identical to the training phase. Cue-induced drug craving was then assessed at 2 and 21 days after the footshock phase. All rats escalated their intake of METH, with both phenotypes showing similar drug taking patterns during SA training. In addition, rats that continued their METH intake despite negative consequences showed even greater cue-induced drug craving following withdrawal than the rats that reduced METH intake following negative consequences. Taken together, our adverse consequence-based model highlights the possibility of identifying rats by addiction-like phenotypes and subsequent vulnerability to relapse-like behaviors. The use of similar SA models should help in the development of better therapeutic approaches to treat different stages of METH addiction. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
6. Dietary energy intake modifies brainstem autonomic dysfunction caused by mutant α-synuclein
- Author
-
Griffioen, Kathleen J., Rothman, Sarah M., Ladenheim, Bruce, Wan, Ruiqian, Vranis, Neil, Hutchison, Emmette, Okun, Eitan, Cadet, Jean Lud, and Mattson, Mark P.
- Subjects
- *
BRAIN stem diseases , *CARE of Parkinson's disease patients , *DYSAUTONOMIA , *SYNUCLEINS , *HEART rate monitoring , *AUTONOMIC nervous system physiology , *SUBSTANTIA nigra - Abstract
Abstract: Parkinson''s disease (PD) patients often exhibit impaired regulation of heart rate by the autonomic nervous system (ANS) that may precede motor symptoms in many cases. Results of autopsy studies suggest that brainstem pathology, including the accumulation of α-synuclein, precedes damage to dopaminergic neurons in the substantia nigra in PD. However, the molecular and cellular mechanisms responsible for the early dysfunction of brainstem autonomic neurons are unknown. Here we report that mice expressing a mutant form of α-synuclein that causes familial PD exhibit aberrant autonomic control of the heart characterized by elevated resting heart rate and an impaired cardiovascular stress response, associated with reduced parasympathetic activity and accumulation of α-synuclein in the brainstem. These ANS abnormalities occur early in the disease process. Adverse effects of α-synuclein on the control of heart rate are exacerbated by a high energy diet and ameliorated by intermittent energy restriction. Our findings establish a mouse model of early dysregulation of brainstem control of the cardiovascular system in PD, and further suggest the potential for energy restriction to attenuate ANS dysfunction, particularly in overweight individuals. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
7. Methamphetamine treatment causes delayed decrease in novelty-induced locomotor activity in mice
- Author
-
Krasnova, Irina N., Hodges, Amber B., Ladenheim, Bruce, Rhoades, Raina, Phillip, Crystal G., Ceseňa, Angela, Ivanova, Ekaterina, Hohmann, Christine F., and Cadet, Jean Lud
- Subjects
- *
PHARMACODYNAMICS , *METHAMPHETAMINE , *DOPAMINERGIC neurons , *NERVOUS system injuries , *LABORATORY mice , *NEUROTOXIC agents , *CELL death , *NEUROTOXICOLOGY - Abstract
Abstract: Methamphetamine (METH) is a psychostimulant that causes damage to dopamine (DA) axons and to non-monoaminergic neurons in the brain. The aim of the present study was to investigate short- and long-term effects of neurotoxic METH treatment on novelty-induced locomotor activity in mice. Male BALB/c mice, 12–14 weeks old, were injected with saline or METH (i.p., 7.5mg/kg×4 times, every 2h). Behavior and neurotoxic effects were assessed at 10 days, 3 and 5 months following drug treatment. METH administration caused marked decreases in DA levels in the mouse striatum and cortex at 10 days post-drug. However, METH did not induce any changes in novelty-induced locomotor activity. At 3 and 5 months after treatment METH-exposed mice showed significant recovery of DA levels in the striatum and cortex. In contrast, these animals demonstrated significant decreases in locomotor activity at 5 months in comparison to aged-matched control mice. Further assessment of METH toxicity using TUNEL staining showed that the drug induced increased cell death in the striatum and cortex at 3 days after administration. Taken together, these data suggest that delayed deficits in novelty-induced locomotor activity observed in METH-exposed animals are not due to neurodegeneration of DA terminals but to combined effects of METH and age-dependent dysfunction of non-DA intrinsic striatal and/or corticostriatal neurons. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
8. l-Dopa induced dyskinesias in Parkinsonian mice: Disease severity or l-Dopa history.
- Author
-
Shan, Lufei, Diaz, Oscar, Zhang, Yajun, Ladenheim, Bruce, Cadet, Jean-Lud, Chiang, Yung-Hsiao, Olson, Lars, Hoffer, Barry J., and Bäckman, Cristina M.
- Subjects
- *
DOPA , *DYSKINESIAS , *TREATMENT effectiveness , *PARKINSON'S disease treatment , *DOPAMINE , *NEURAL transmission , *LABORATORY mice - Abstract
In Parkinson’s disease, the efficacy of l -Dopa treatment changes over time, as dyskinesias emerge with previously beneficial doses. Using MitoPark mice, that models mitochondrial failure in dopamine (DA) neurons and mimics the progressive loss of dopamine observed in Parkinson’s disease, we found that the severity of DA denervation and associated adaptations in striatal neurotransmission at the time of initiation of l -Dopa treatment determines development of l -Dopa induced dyskinesias. We treated 20-week, and 28-week old MitoPark mice with l -Dopa (10 mg/kg i.p. twice a day) and found locomotor responses to be significantly different. While all MitoPark mice developed sensitization to l -Dopa treatment over time, 28-week old MitoPark mice with extensive striatal DA denervation developed abnormal involuntary movements rapidly and severely after starting l -Dopa treatment, as compared to a more gradual escalation of movements in 20-week old animals that started treatment at earlier stages of degeneration. Our data support that it is the extent of loss of DA innervation that determines how soon motor complications develop with l -Dopa treatment. Gene array studies of striatal neurotransmitter receptors revealed changes in mRNA expression levels for DA, serotonin, glutamate and GABA receptors in striatum of 28-week old MitoPark mice. Our results support that delaying l -Dopa treatment until Parkinson’s disease symptoms become more severe does not delay the development of l -Dopa-induced dyskinesias. MitoPark mice model genetic alterations known to impair mitochondrial function in a subgroup of Parkinson patients and provide a platform in which to study treatments to minimize the development of dyskinesia. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
9. Methamphetamine Downregulates Striatal Glutamate Receptors via Diverse Epigenetic Mechanisms.
- Author
-
Jayanthi, Subramaniam, McCoy, Michael T., Chen, Billy, Britt, Jonathan P., Kourrich, Saїd, Yau, Hau-Jie, Ladenheim, Bruce, Krasnova, Irina N., Bonci, Antonello, and Cadet, Jean Lud
- Subjects
- *
METHAMPHETAMINE , *GENETIC regulation , *GLUTAMATE receptors , *EPIGENETICS , *NEUROPLASTICITY , *SYNAPSES - Abstract
Background: Chronic methamphetamine (METH) exposure causes neuroadaptations at glutamatergic synapses. Methods: To identify the METH-induced epigenetic underpinnings of these neuroadaptations, we injected increasing METH doses to rats for 2 weeks and measured striatal glutamate receptor expression. We then quantified the effects of METH exposure on histone acetylation. We also measured METH-induced changes in DNA methylation and DNA hydroxymethylation. Results: Chronic METH decreased transcript and protein expression of GluA1 and GluA2 alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) and GluN1 N-methyl-D-aspartate receptor subunits. These changes were associated with altered electrophysiological glutamatergic responses in striatal neurons. Chromatin immunoprecipitation-polymerase chain reaction revealed that METH decreased enrichment of acetylated histone H4 on GluA1, GluA2, and GluN1 promoters. Methamphetamine exposure also increased repressor element-1 silencing transcription factor (REST) corepressor 1, methylated CpG binding protein 2, and histone deacetylase 2 enrichment, but not of sirtuin 1 or sirtuin 2, onto GluA1 and GluA2 gene sequences. Moreover, METH caused interactions of REST corepressor 1 and methylated CpG binding protein 2 with histone deacetylase 2 and of REST with histone deacetylase 1. Surprisingly, methylated DNA immunoprecipitation and hydroxymethylated DNA immunoprecipitation-polymerase chain reaction revealed METH-induced decreased enrichment of 5-methylcytosine and 5-hydroxymethylcytosine at GluA1 and GluA2 promoter sequences. Importantly, the histone deacetylase inhibitor, valproic acid, blocked METH-induced decreased expression of AMPAR and N-methyl-D-aspartate receptor subunits. Finally, valproic acid also attenuated METH-induced decrease H4K16Ac recruitment on AMPAR gene sequences. Conclusions: These observations suggest that histone H4 hypoacetylation may be the main determinant of METH-induced decreased striatal glutamate receptor expression. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
10. Prenatal Interaction of Mutant DISC1 and Immune Activation Produces Adult Psychopathology
- Author
-
Abazyan, Bagrat, Nomura, Jun, Kannan, Geetha, Ishizuka, Koko, Tamashiro, Kellie L., Nucifora, Frederick, Pogorelov, Vladimir, Ladenheim, Bruce, Yang, Chunxia, Krasnova, Irina N., Cadet, Jean Lud, Pardo, Carlos, Mori, Susumu, Kamiya, Atsushi, Vogel, Michael W., Sawa, Akira, Ross, Christopher A., and Pletnikov, Mikhail V.
- Subjects
- *
MENTAL illness genetics , *GENOTYPE-environment interaction , *PATHOLOGICAL psychology , *SCHIZOPHRENIA , *NEURAL transmission , *AFFECTIVE disorders , *LABORATORY mice - Abstract
Background: Gene-environment interactions (GEI) are involved in the pathogenesis of mental diseases. We evaluated interaction between mutant human disrupted-in-schizophrenia 1 (mhDISC1) and maternal immune activation implicated in schizophrenia and mood disorders. Methods: Pregnant mice were treated with saline or polyinosinic:polycytidylic acid at gestation day 9. Levels of inflammatory cytokines were measured in fetal and adult brains; expression of mhDISC1, endogenous DISC1, lissencephaly type 1, nuclear distribution protein nudE-like 1, glycoprotein 130, growth factor receptor-bound protein 2, and glycogen synthase kinase-3beta were assessed in cortical samples of newborn mice. Tissue content of monoamines, volumetric brain abnormalities, dendritic spine density in the hippocampus, and various domains of the mouse behavior repertoire were evaluated in adult male mice. Results: Prenatal interaction produced anxiety, depression-like responses, and altered social behavior that were accompanied by decreased reactivity of the hypothalamic-pituitary-adrenal axis, attenuated serotonin neurotransmission in the hippocampus, reduced enlargement of lateral ventricles, decreased volumes of amygdala and periaqueductal gray matter and density of spines on dendrites of granule cells of the hippocampus. Prenatal interaction modulated secretion of inflammatory cytokines in fetal brains, levels of mhDISC1, endogenous mouse DISC1, and glycogen synthase kinase-3beta. The behavioral effects of GEI were observed only if mhDISC1 was expressed throughout the life span. Conclusions: Prenatal immune activation interacted with mhDISC1 to produce the neurobehavioral phenotypes that were not seen in untreated mhDISC1 mice and that resemble aspects of major mental illnesses. Our DISC1 mouse model is a valuable system to study GEI relevant to mental illnesses. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
11. Differential effects of methamphetamine and SCH23390 on the expression of members of IEG families of transcription factors in the rat striatum
- Author
-
Beauvais, Genevieve, Jayanthi, Subramaniam, McCoy, Michael T., Ladenheim, Bruce, and Cadet, Jean Lud
- Subjects
- *
METHAMPHETAMINE , *EFFECT of drugs on the brain , *DOPAMINE antagonists , *CELLULAR signal transduction , *PHARMACOGENOMICS , *GENE expression , *LABORATORY rats , *TRANSCRIPTION factors - Abstract
Abstract: Methamphetamine (METH) is a psychostimulant that can cause long-lasting neurodegenerative effects in humans and animals. These toxic effects appear to occur, in part, via activation of dopamine (DA) D1 receptors. This paper assessed the possibility that the DA D1 receptor antagonist, SCH23390, might inhibit METH-induced changes in the expression of several members of immediate early genes (IEGs) which are known to control more delayed expression of other genes. We found that injections of METH (4×10 mg/kg, given at 2 h intervals) caused significant increases in c-fos and fra-2 expression which lasted from 30 min to 4 h. Pre-treatment with SCH23390, given 30 min before each METH injection, completely blocked METH-induced expression of c-fos, but only partially inhibited fra-2 mRNA expression. These results were confirmed by Western blot analysis which showed METH-induced changes in c-Fos protein expression that were blocked by pretreatment with SCH23390. There were also delayed METH-induced DA D1 receptor-dependent effects on fosB mRNA expression. Even though fra-1 expression was not affected by pretreatment with METH alone, the repeated injections of SCH23390 caused substantial decreases in fra-1 mRNA expression in both the presence and absence of METH. The repeated injections of METH caused no changes in the mRNAs for c-jun, junB or junD. However, there were significant increases in the phosphorylation of c-Jun protein (ser63). Phosphorylation of c-Jun occurred in a delayed fashion (16 and 24 h after the last METH injections) and was attenuated by SCH23390 pretreatment. Interestingly, SCH23390 given alone caused significant decreases in phospho-c-Jun at all time-points. The METH injections also caused delayed induction in the expression of members of the Egr family of transcription factors in a DA D1 receptor-dependent fashion. Repeated injections of SCH23390 caused substantial suppression of basal striatal egr-1 and egr-2 mRNA expression but not of that of egr-3. Both crem and arc mRNA levels were induced by METH in a SCH23390-sensitive fashion. Moreover, multiple injections of SCH23390 given alone caused marked inhibition of basal arc expression. These results show that multiple injections of METH can differentially affect the expression of several IEGs, some of which occurred in a DA D1 receptor dependent fashion. The SCH23390-mediated suppression of basal fra-1, egr-1, and egr-2 mRNA levels suggests that their basal expression in the striatum might be dependent on tonic stimulation of the DA D1 receptor. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
12. Growth Factor Signals in Neural Cells: COHERENT PATTERNS OF INTERACTION CONTROL MULTIPLE LEVELS OF MOLECULAR AND PHENOTYPIC RESPONSES.
- Author
-
Martin, Bronwen, Brenneman, Randall, Golden, Erin, Walent, Tom, Becker, Kevin G., Prabhu, Vinayakumar V., Wood III, William, Ladenheim, Bruce, Cadet, Jean-Lud, and Maudsley, Stuart
- Subjects
- *
NERVE growth factor , *SOMATOMEDIN , *EPIDERMAL growth factor , *TRANSCRIPTION factors , *NEUROTRANSMITTERS , *PHENOTYPES - Abstract
Individual neurons express receptors for several different growth factors that influence the survival, growth, neurotransmitter phenotype, and other properties of the cell. Although there has been considerable progress in elucidating the molecular signal transduction pathways and physiological responses of neurons and other cells to individual growth factors, little is known about if and how signals from different growth factors are integrated within a neuron. In this study, we determined the interactive effects of nerve growth factor, insulin-like growth factor 1, and epidermal growth factor on the activation status of downstream kinase cascades and transcription factors, cell survival, and neurotransmitter production in neural cells that express receptors for all three growth factors. We document considerable differences in the quality and quantity of intracellular signaling and eventual phenotypic responses that are dependent on whether cells are exposed to a single or multiple growth factors. Dual stimulations that generated the greatest antagonistic or synergistic actions, compared with a theoretically neutral summation of their two activities, yielded the largest eventual change of neuronal phenotype indicated by the ability of the cell to produce norepinephrine or resist oxidative stress. Combined activation of insulin-like growth factor 1 and epidermal growth factor receptors was particularly notable for antagonistic interactions at some levels of signal transduction and norepinephrine production, but potentiation at other levels of signaling and cytoprotection. Our findings suggest that in true physiological settings where multiple growth factors are present, activation of one receptor type may result in molecularand phenotypic responses that are different from that observed in typical experimental paradigms in which cells are exposed to only a single growth factor at a time. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
13. Environmental enrichment during adolescence regulates gene expression in the striatum of mice
- Author
-
Thiriet, Nathalie, Amar, Lahouari, Toussay, Xavier, Lardeux, Virginie, Ladenheim, Bruce, Becker, Kevin G., Cadet, Jean Lud, Solinas, Marcello, and Jaber, Mohamed
- Subjects
- *
GENE expression , *NEUROTOXIC agents , *METHYLPHENYLTETRAHYDROPYRIDINE , *MICE - Abstract
Abstract: We have previously shown that environmental enrichment decreases the activating and rewarding effects of the psychostimulant cocaine and increases resistance to the neurotoxic effect of the Parkinson-inducing drug MPTP. These effects were accompanied by an increase in the striatal expression of the neurotrophin BDNF, an increase in the striatal levels of delta-Fos B and by a decrease in striatal levels of the dopamine transporter, the main molecular target for cocaine and MPTP. Here, we used cDNA arrays to investigate the effects of rearing mice in enriched environments from weaning to adulthood on the profile of expression of genes in the striatum focusing on genes involved in intracellular signalling and functioning. We found that mice reared in an enriched environment show several alterations in the levels of mRNA coding for proteins involved in cell proliferation, cell differentiation, signal transduction, transcription and translation, cell structure and metabolism. Several of these findings were further confirmed by real-time quantitative PCR and, in the case of protein kinase C lambda, also by western blot. These findings are the first description of alterations in striatal gene expression by an enriched environment. The striatal gene expression regulation by environment that we report here may play a role in the resistance to the effects of drugs of abuse and dopaminergic neurotoxins previously reported. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.